Patient Leaflet Updated 30-Jan-2023 | Ranbaxy (UK) Limited a Sun Pharmaceutical Company
Caspofungin 50 mg or 70 mg powder for concentrate for solution for infusion
Caspofungin 50 mg powder for concentrate for solution for infusion
Caspofungin 70 mg powder for concentrate for solution for infusion
Caspofungin
1. What Caspofungin is and what it is used for
2. What you need to know before you are given Caspofungin
3. How Caspofungin is given
4. Possible side effects
5. How to store Caspofungin
6. Contents of the pack and other information
Caspofungin contains a medicine called caspofungin. This belongs to a group of medicines called antifungals.
Caspofungin is used to treat the following infections in children, adolescents and adults:
Caspofungin makes fungal cells fragile and stops the fungus from growing properly. This stops the infection from spreading and gives the body’s natural defenses a chance to completely get rid of the infection.
If you are not sure, talk to your doctor, nurse or pharmacist before you are given your medicine.
Talk to your doctor, nurse or pharmacist before you are given Caspofungin:
If any of the above applies to you (or you are not sure), talk to your doctor, nurse or pharmacist before you are given Caspofungin.
Caspofungin may also cause Serious Cutaneous Adverse Reactions such as Stevens-Johnson Syndrome (SJS) and toxic epidermal necrolysis (TEN).
Tell your doctor, nurse or pharmacist if you are taking, have recently taken or might take any other medicines. This includes medicines obtained without a prescription, including herbal medicines. This is because Caspofungin can affect the way some other medicines work. Also some other medicines can affect the way Caspofungin works.
Tell your doctor, nurse or pharmacist if you are taking any of the following medicines:
If any of the above apply to you (or you are not sure), talk to your doctor, nurse or pharmacist before you are given Caspofungin.
Ask your doctor for advice before taking any medicine, if you are pregnant or breast-feeding or think you are pregnant.
There is no information to suggest that Caspofungin affects your ability to drive or operate machinery.
This medicine contains less than 1 mmol sodium (23 mg) per vial, that is to say essentially ‘sodium-free’.
Caspofungin will always be prepared and given to you by a healthcare professional.
You will be given Caspofungin:
Your doctor will determine the duration of your treatment and how much Caspofungin you will be given each day. Your doctor will monitor how well the medicine works for you. If you weigh more than 80 kg, you may need a different dose.
The dose for children and adolescents may differ from the adult dose.
Your doctor will decide how much Caspofungin you need and for how long each day. If you are worried that you may have been given too much Caspofungin, tell your doctor or nurse straight away.
If you have any further questions on the use of this medicine, ask your doctor, nurse or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
As with any prescription medicine, some side effects may be serious. Ask your doctor for more information.
Other side effects in adults include:
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Very common (may affect more than 1 in 10 people):
Common (may affect up to 1 in 10 people):
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and the vial after EXP. The expiry date refers to the last day of that month.
Unopened vials: Store in a refrigerator at 2°C to 8°C.
Chemical and physical in-use stability has been demonstrated for up to 24 hours at 25 °C or less and at 5 ± 3 °C when reconstituted with water for injection. From a microbiological point of view, unless the method of opening/reconstitution/dilution precludes the risk of microbiological contamination, the product should be used immediately.
This is because it does not contain any ingredients to stop the growth of bacteria. If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user.
Chemical and physical in-use stability of the diluted patient infusion solution has been demonstrated for 48 hours at 2 to 8°C and at room temperature (25 °C), when diluted with sodium chloride solution 9 mg/ml (0.9 %), 4.5 mg/ml (0.45 %), or 2.25 mg/ml (0.225 %) for infusion, or lactated Ringer’s solution.
From a microbiological point of view, the product should be used immediately. If not used immediately, in use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8°C, unless reconstitution and dilution have taken place in controlled validated aseptic conditions.
Only a trained healthcare professional who has read the complete directions should prepare the medicine (please see below “Instructions of how to reconstitute and dilute Caspofungin”).
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Caspofungin is a sterile, white to off-white lyophilised powder.
Each pack contains one vial (10 ml) of powder.
Marketing Authorisation Holder
Manufacturer
For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder.
This medicinal product is authorised in the Member States of the EEA under the following names:
Denmark Caspofungin SUN 50 mg pulver til koncentrat til infusionsvæske, opløsning
Caspofungin SUN 70 mg pulver til koncentrat til infusionsvæske, opløsning
Spain Caspofungin SUN 50 mg polvo para concentrada para solucio para perfusion EFG
Caspofungin SUN 70 mg polvo para concentrada para solucio para perfusion EFG
France Caspofungine SUN 50 mg, poudre pour solution à diluer pour perfusion
Caspofungine SUN 70 mg, poudre pour solution à diluer pour perfusion
Italy Caspofungin SUN
Germany Caspofungin SUN 50 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Caspofungin SUN 70 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
United Kingdom Caspofungin 50 mg powder for concentrate for solution for infusion
Caspofungin 70 mg powder for concentrate for solution for infusion
Romania Caspofungina Terapia 50mg pulbere pentru concentrat pentru soluţie perfuzabilă
Caspofungina Terapia 70mg pulbere pentru concentrat pentru soluţie perfuzabilă
This leaflet was last revised in September 2022.
6-9 The Square, Stockley Park, Uxbridge, UB11 1FW, UK
+44 (0) 208 848 5052